Richard Polakoff
Cardiovascular Disease · Lauderdale Lakes, FLNPI 1356315303
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 206 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $4,009 and has fallen 91.2% since, to $354 in 2023.
Across 206 payments — averaging $43.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$2K
- Novo Nordisk$1K
- Boehringer Ingelheim$944
- AstraZeneca$936
- Johnson & Johnson$762
- Sanofi-aventis U.S. LLC$754
- plus $3K from 17 others
What the payments were for
- Consulting fees$350%
- Speaking & faculty fees$501%
- Food & beverage$8,92699%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 11 | $1,607 |
| Novo Nordisk | 48 | $1,320 |
| Boehringer Ingelheim | 18 | $944 |
| AstraZeneca | 24 | $936 |
| Johnson & Johnson(2 entities) | 8 | $762 |
| Sanofi-aventis U.S. LLC | 27 | $754 |
| Abbott | 6 | $680 |
| Lilly USA, LLC | 29 | $435 |
| GSK | 4 | $361 |
| Medtronic | 2 | $166 |
| Novartis | 7 | $154 |
| AbbVie | 1 | $125 |
| Heartflow, Inc. | 1 | $125 |
| Vifor Pharma, Inc. | 1 | $125 |
| Mylan Specialty L.p. | 1 | $125 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Merck | 6 | $102 |
| Bayer | 3 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Pfizer | 2 | $39 |
| Corcept Therapeutics | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATRICLIP LAA EXCLUSION SYSTEM$652
- XARELTO$597
- JARDIANCE$589
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$561
- SYNERGY ABLATION SYSTEM$524
- FARXIGA$495
- Ozempic$484
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$408
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$378
- Bioprosthetic Mitral Valve$295
- EPI-SENSE GUIDED COAGULATION SYS$250
- TRELEGY ELLIPTA$246
- SOLIQUA 100/33$237
- MitraClip$170
- Claria MRI$131
- UBRELVY$125
- BREZTRI$125
- FFRct$125
- Veltassa$125
- Yupelri$125
How this compares
$9,033 in reported general payments places this provider in the 75th percentile of 1,740 cardiovascular disease providers in Florida.
Other cardiovascular disease in Lauderdale Lakes
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
- Seth BaumBoca Raton$517K
- Elliott EliasMiami$497K
- Vijay HaryaniVero Beach$413K
- Neel PatelMaitland$392K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.